NASDAQ · DCGOHealthcareHealth Services

DocGo financials

$0.3680+0.82%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
FY23
Dec 31
FY22
Dec 31
FY21
Dec 31
Revenue$322.2M$616.6M$624.3M$440.5M$318.7M
Gross profit$98.8M$213.6M$195.4M$154.7M$109.7M
Gross margin30.7%34.6%31.3%35.1%34.4%
Operating income-$178.0M$28.7M$15.1M$21.8M$15.4M
Net income-$182.4M$20.0M$6.9M$34.6M$23.7M
Net margin−56.6%3.2%1.1%7.9%7.4%
Diluted EPS$-1.84$0.18$0.06$0.34$0.25
EBITDA-$54.9M$57.1M$38.2M$32.4M$22.4M
Operating cash flow$34.5M$70.1M-$64.5M$28.9M-$1.9M
Free cash flow$29.9M$66.5M-$71.8M$25.7M-$6.8M
Diluted shares99.1M109.4M105.6M103.0M94.9M

Balance sheet

Period endDec 31Dec 31Dec 31Dec 31Dec 31
Cash & equivalents$51.0M$89.2M$59.3M$157.3M$175.5M
Short-term investments$0.00$0.00$0.00$0.00—
Total debt$17.0M$44.7M$36.5M$10.5M$8.8M
Total assets$217.1M$455.6M$490.5M$393.3M$309.6M
Total liabilities$91.2M$140.4M$185.3M$114.4M$82.5M
Shareholders' equity$125.9M$315.2M$305.2M$278.9M$227.1M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology